European Healthcare Acquisition & Growth Company B.V.

European Healthcare Acquisition & Growth Company B.V. announces intention to extend Business Combination Deadline, to offer redemption of Public Shares and to terminate all Public and Sponsor Warrants

European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH terminate discussion on business combination

General meeting of shareholders of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions

European Healthcare Acquisition & Growth Company B.V. removes shareholders’ votes on proposed business combination with Croma-Pharma GmbH from agenda of general meeting

European Healthcare Acquisition & Growth Company B.V. received redemption notices with respect to EUR 185.85 million – minimum net cash condition is not yet fulfilled

European Healthcare Acquisition & Growth Company B.V.: Public disclosure of inside information

European Healthcare Acquisition & Growth Company B.V convenes annual general meeting of shareholders and publishes shareholder circular relating to proposed business combination with Croma-Pharma GmbH

European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH, agree on adjusted enterprise value of Croma, and Sponsors waive 20% sponsor shares and devalue 20% sponsor warrants  

European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report 2022 (news with additional features)

European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH signed Business Combination Agreement

European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH in advanced discussions about a potential business combination

European Healthcare Acquisition & Growth Company B.V. publishes its Half Year Report for the period from 1 January 2022 to 30 June 2022 (news with additional features)

General meeting of shareholders of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions (news with additional features)

​​​​​​​European Healthcare Acquisition & Growth Company B.V. retracts notice regarding reconvening its annual general meeting of shareholders (news with additional features)

European Healthcare Acquisition & Growth Company B.V. reconvenes its annual general meeting of shareholders subject to extension of temporary Dutch COVID-19 Act (Tijdelijke wet Justitie en Veiligheid) (news with additional features)

European Healthcare Acquisition & Growth Company B.V. convenes the annual general meeting of shareholders and publishes the agenda thereof (news with additional features)

European Healthcare Acquisition & Growth Company B.V. publishes its annual report for the period from 9 July 2021 to 31 December 2021

European Healthcare Acquisition & Growth Company B.V.: Former German healthcare leader of McKinsey & Company, Thomas Rudolph, takes office

European Healthcare Acquisition & Growth Company B.V. – Home Member State Notification

High-profile sponsor team completes EUR 200 million private placement for first-of-its-kind novel acquisition and growth company in the European healthcare sector

European Healthcare Acquisition & Growth Company B.V. completes EUR 200 million private placement

European Healthcare: Sponsor team with outstanding track record launches first-of-its-kind novel acquisition and growth vehicle in the European healthcare sector

European Healthcare Acquisition & Growth Company B.V. announces bookbuilding for up to EUR 200 million private placement